Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by mimicking a hormone that regulates blood sugar and appetite. Unlike daily medications, semaglutide requires just one injection per week, making it convenient for long-term weight management. Understanding the injection schedule and proper administration technique helps maximize therapeutic benefit and minimize injection-site discomfort.
Weekly Semaglutide Injection Frequency and Schedule
Semaglutide is administered as a subcutaneous injection once every seven days on the same day each week. This consistent weekly timing allows the medication to maintain steady levels in your bloodstream, supporting appetite suppression and improved glucose control. Most patients choose a convenient day like Monday or Friday to help them remember their injection schedule.
The actual dose amount increases gradually over your treatment course, but the injection frequency remains constant at one time per week regardless of dose level. Your body absorbs the medication slowly over the seven-day period, which is why daily injections are not necessary. This weekly delivery system distinguishes semaglutide from older diabetes medications that required multiple daily doses.
Understanding the Semaglutide Dose Escalation Timeline
Most semaglutide treatment plans follow a 4-week escalation phase during which your dose gradually increases in small increments. This slower start allows your digestive system to adapt and reduces the likelihood of nausea or other gastrointestinal side effects. PlexusDx providers personalize escalation timing based on your tolerance and clinical response, meaning your dose may need to go up—but your price won't.
The typical escalation pattern begins at 0.25 mg in week one, increases to 0.5 mg by week two, then progresses to 1.0 mg, 1.7 mg, and potentially 2.4 mg at therapeutic levels. Some patients achieve desired weight loss results at intermediate doses, while others benefit from reaching the maximum recommended dose. Your PlexusDx provider monitors your progress and adjusts the pace of dose increases to match your individual needs and tolerability.
Proper Subcutaneous Injection Technique for Semaglutide
Semaglutide injections are administered subcutaneously, meaning the medication is delivered into the fatty tissue beneath your skin rather than into muscle. Common injection sites include the abdomen, thigh, or upper arm, and rotating injection locations helps prevent skin irritation and lipohypertrophy (thickened fat deposits). Most patients inject at a 90-degree angle using a 30-gauge needle, and the entire injection takes less than one minute to complete.
Before injecting, allow your semaglutide pen or vial to reach room temperature for 15-30 minutes, as cold medication may be more uncomfortable and can affect absorption. Wash the injection site with soap and water, then gently pinch the skin to create a pocket for needle insertion. After injecting, hold the needle in place for three to five seconds before withdrawing to ensure complete medication delivery, then massage the area gently for a few seconds post-injection.
PlexusDx Compounded Semaglutide and Personalized Treatment Plans
PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies, providing high-quality medication at predictable monthly pricing starting at $149/mo. Compounded formulations are prepared specifically for each patient under strict pharmaceutical standards, ensuring purity and potency that matches brand-name products. PlexusDx serves all 50 states without requiring insurance, and treatment is HSA/FSA eligible for added financial flexibility.
Beyond standard semaglutide dosing, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month), which analyzes genetic variants in key pathways like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 to predict medication response. This genetic insight helps your provider tailor your injection schedule and escalation timeline based on your unique peptide biology, potentially improving outcomes and reducing trial-and-error adjustments.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I inject semaglutide every day or just once a week?
Semaglutide is injected once per week on the same day each week. The medication is absorbed slowly over seven days, maintaining steady therapeutic levels without daily doses. This weekly schedule is one of the primary advantages over older diabetes treatments.
What happens if I miss my weekly semaglutide injection?
If you miss your scheduled injection, administer it as soon as you remember unless your next dose is within two days. Resume your normal weekly schedule after that injection. Missing occasional doses may reduce appetite suppression temporarily but will not cause serious harm; consistent adherence optimizes weight loss and metabolic benefits.
Does PlexusDx charge more if my semaglutide dose increases?
No. PlexusDx offers compounded semaglutide at a flat rate of $149/mo regardless of dose level across all commitment tiers. Your dose may need to go up, but your price won't—making long-term therapy predictable and affordable.
What are common side effects from weekly semaglutide injections?
Nausea, constipation, and mild injection-site reactions are the most frequently reported side effects, particularly during the dose escalation phase. These effects typically diminish within days to weeks as your body adapts. Serious adverse events are rare; report persistent nausea, severe abdominal pain, or injection-site infections to your healthcare provider immediately.
Can the Precision Peptide Genetic Test predict how I'll respond to semaglutide injections?
Yes. PlexusDx's Precision Peptide Genetic Test analyzes variants in the GLP1R, GIPR, and MC4R genes that influence how your body responds to GLP-1 medications. Understanding your genetic predispositions helps your provider optimize your injection schedule and escalation timeline for better weight loss outcomes and tolerability.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Get Semaglutide from a Compounding Pharmacy?
How Do You Feel After First Shot of Ozempic: What to Expect